- Home
- LOOP vs ABOS Comparison
LOOP vs ABOS Comparison
Compare LOOP & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOOP
- ABOS
- Stock Information
- Founded
- LOOP 2010
- ABOS 1996
- Country
- LOOP Canada
- ABOS United States
- Employees
- LOOP N/A
- ABOS N/A
- Industry
- LOOP Major Chemicals
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- LOOP Industrials
- ABOS Health Care
- Exchange
- LOOP Nasdaq
- ABOS Nasdaq
- Market Cap
- LOOP 72.5M
- ABOS 85.4M
- IPO Year
- LOOP N/A
- ABOS 2021
- Fundamental
- Price
- LOOP $1.53
- ABOS $1.31
- Analyst Decision
- LOOP
- ABOS Strong Buy
- Analyst Count
- LOOP 0
- ABOS 3
- Target Price
- LOOP N/A
- ABOS $8.00
- AVG Volume (30 Days)
- LOOP 94.4K
- ABOS 244.1K
- Earning Date
- LOOP 10-14-2025
- ABOS 08-12-2025
- Dividend Yield
- LOOP N/A
- ABOS N/A
- EPS Growth
- LOOP N/A
- ABOS N/A
- EPS
- LOOP N/A
- ABOS N/A
- Revenue
- LOOP $11,135,000.00
- ABOS N/A
- Revenue This Year
- LOOP N/A
- ABOS N/A
- Revenue Next Year
- LOOP $777.41
- ABOS N/A
- P/E Ratio
- LOOP N/A
- ABOS N/A
- Revenue Growth
- LOOP 8335.61
- ABOS N/A
- 52 Week Low
- LOOP $0.85
- ABOS $0.86
- 52 Week High
- LOOP $2.29
- ABOS $3.36
- Technical
- Relative Strength Index (RSI)
- LOOP 52.88
- ABOS 49.93
- Support Level
- LOOP $1.39
- ABOS $1.39
- Resistance Level
- LOOP $1.59
- ABOS $1.60
- Average True Range (ATR)
- LOOP 0.09
- ABOS 0.10
- MACD
- LOOP -0.01
- ABOS -0.00
- Stochastic Oscillator
- LOOP 48.28
- ABOS 51.22
About LOOP Loop Industries Inc.
Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.